… Immunoglobulin therapy is considered another potential treatment for COVID-19 patients. …
(ARDS), but whether these therapies are effective for treating COVID-19 remain unknown. Few …

… therapy strategies for COVID-19, with an emphasis on antiviral agents, neutralizing antibody
therapies… When necessary, specific mechanisms and the history of therapy are present, and …

… The virus SARS-CoV-2, the etiological agent of COVID-19, is … since its emergence, COVID-19
is now causing multiple … literature surrounding unproven therapies for COVID-19. Analyses …

… As the COVID-19 pandemic … therapies for COVID-19 with an emphasis on experience with
severe acute respiratory syndrome-associated coronavirus (SARS-COV-1) (COVID-19 has …

… Authorities and physicians are still learning how COVID-19 affects people with underlying …
therapies during the COVID-19 pandemic in patients with asthma for whom such therapies are …

… are all at increased risk of adverse COVID-19 outcomes 2,3 . … the RCTs of novel therapies
for COVID-19, presumably owing … these therapies in the prevention and treatment of COVID-19-…

… 5.1 Current therapies Given the lack of effective antiviral therapy against COVID-19, current
… Diagnosis and Treatment of Pneumonia Caused by COVID-19 (updated to version 6) issued …

… did show some efficacy of IFN therapies in reducing mortality and improving hospitalisation
outcomes [64, 65, 67], suggesting that these therapies may warrant further investigation. …

… efficacy in non-COVID-19-related pathologies, clinical trials of MSC-based therapy in patients
with severe COVID-19 have been initiated in China and two trials are currently ongoing. …

… Thus, according to the results of this analysis, none of the considered methods of COVID-19
therapy showed a significantly positive effect on mortality or a significant effectiveness in …